🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Drugs Made In America Acquisition II Corp.

DMII Financials
$10.01 $0 (0.00%)
Market Cap: $637.64 M
Gurus Holding
1
Popularity Rank
#4921
% of Shares Held
1.18%
Net Activity (Q4 2025)
+$7.42 M

Guru Ownership Trend

Guru Analysis for Drugs Made In America Acquisition II Corp. (DMII)

Drugs Made In America Acquisition II Corp. (DMII), a key player in the Financials sector, continues to attract institutional attention.

As of Q4 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $7.51 M.

Top institutional holders include Louis Moore Bacon.

Institutional sentiment is currently Bullish. This is evidenced by a $7.42 M net inflow during the quarter.

Recent activity highlights Louis Moore Bacon who opened a new position.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$7.42 M
Total Buy Value
New Buys 1
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
1

FAQs for Drugs Made In America Acquisition II Corp. (DMII)

Major holders include Louis Moore Bacon ($7.42 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 750,000 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.42 M, with 1 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in DMII during the most recent reporting period.

Yes, 1 managers opened new positions in DMII, and 0 increased their existing holdings. The total reported buy value was $7.42 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.11% New Buy 750,000 $7.42 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form